Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy

SIMPLE SUMMARY: Brain metastases are common in melanoma and are often associated with significant morbidity and mortality. Although many new treatments for melanoma have been approved in recent years, including immune checkpoint inhibitors and BRAF/MEK inhibitors, limited data are available for surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Rieth, John M., Swami, Umang, Mott, Sarah L., Zanaty, Mario, Henry, Michael D., Bossler, Aaron D., Greenlee, Jeremy D., Zakharia, Yousef, Vanneste, Marion, Jennings, Brooke, Milhem, Mohammed M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037963/
https://www.ncbi.nlm.nih.gov/pubmed/33804910
http://dx.doi.org/10.3390/cancers13071489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037963/
https://www.ncbi.nlm.nih.gov/pubmed/33804910
http://dx.doi.org/10.3390/cancers13071489

Ejemplares similares